Fig. 3From: Enhancement of effector functions of anti-CD20 monoclonal antibody by increased afucosylation in CHO cell line through cell culture medium optimizationDose response curve generated by parallel line analysis (PLA) for ADCC activity of test anti-CD20 antibody and control antibody. The test antibody P2-CRD-1508 showed higher ADCC activity due to increase in afucosylation (decrease level of fucosylation) over the control antibody (RS-03-25)Back to article page